Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P35498: Variant p.Leu986Phe

Sodium channel protein type 1 subunit alpha
Gene: SCN1A
Feedback?
Variant information Variant position: help 986 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Leucine (L) to Phenylalanine (F) at position 986 (L986F, p.Leu986Phe). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (L) to large size and aromatic (F) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In DRVT; complete loss of sodium ion transmembrane transport. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 986 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 2009 The length of the canonical sequence.
Location on the sequence: help AMCLTVFMMVMVIGNLVVLN L FLALLLSSFSADNLAATDDD The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         AMCLTVFMMVMVIGNLVVLNLFLALLLSSFSADNLAATDDD

Mouse                         AMCLTVFMMVMVIGNLVVLNLFLALLLSSFSADNLAATDDD

Rat                           AMCLTVFMMVMVIRNLVVLNLFLALLLSSFSADNLAATDDD
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 2009 Sodium channel protein type 1 subunit alpha
Transmembrane 966 – 992 Helical; Name=S6 of repeat II
Repeat 750 – 1022 II
Helix 965 – 994



Literature citations
De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.
Claes L.; Del-Favero J.; Ceulemans B.; Lagae L.; Van Broeckhoven C.; De Jonghe P.;
Am. J. Hum. Genet. 68:1327-1332(2001)
Cited for: VARIANTS DRVT 222-ARG--LYS-2009 DEL AND PHE-986; Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A.
Lossin C.; Rhodes T.H.; Desai R.R.; Vanoye C.G.; Wang D.; Carniciu S.; Devinsky O.; George A.L. Jr.;
J. Neurosci. 23:11289-11295(2003)
Cited for: VARIANT GEFSP2 CYS-1657; CHARACTERIZATION OF VARIANTS GEFSP2 LEU-1353; MET-1656; CYS-1657 AND VAL-1685; CHARACTERIZATION OF VARIANT DRVT PHE-986; FUNCTION; TRANSPORTER ACTIVITY; SUBCELLULAR LOCATION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.